India's First Dengue Vaccine Likely To Be Ready By 2026

Dengue has become a major public health concern in India with 289,235 cases reported last year. This year there were 19,447 cases of dengue which resulted in 19 deaths till April 2024. Kindly......

Parliament should pass law on quota to exceed 50% cap: Congress

The Congress on Sunday said Parliament should pass a law to enable reservations to exceed the 50-per-cent cap, a day after National Democratic Alliance constituent Janata Dal-United demanded that......

New-Gen COVID Jabs Coming Soon...

India currently does not have any XBB 1.5 variant-based vaccines available. IMAGE: A healthcare worker prepares a dose of a COVID-19 vaccine. Photograph: ANI Photo   New-generation Covid......

Should Govt Continue Covid Vax Drive?

India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......

'Aim to be among top three biosimilar players in world'

'We've got a huge track record and success in bringing several biosimilars to the market.' IMAGE: Biocon Biologics, Biocon Park, Bengaluru. Photograph: Kind courtesy Biocon Biologics/Facebook......

Budget 2023: What the pharma, healthcare industry seek

The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Illustration:......

Biocon Biologics Plan Molecule Launch Every 1-2 Years

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.' Photograph: PTI Photo   The market share that Biocon......